Extensive hospital in-ward clustering revealed by molecular characterization of influenza A virus infection.

OBJECTIVE Nosocomial transmission of influenza A virus infection is not fully recognized. The aim of this study was to describe the characteristics of hospitalized patients with influenza A virus (InfA) infection during an entire season and to investigate in-ward transmission at a large acute-care hospital. METHODS During the season 2016-17 all hospitalized patients ≥18 years old with laboratory-verified (real-time PCR) InfA were identified. Cases were characterized according to age, sex, co-morbidity, antiviral therapy, viral load expressed as cycle threshold (Ct) values, length of hospital stay (LOS), 30-day mortality and whether the InfA infection met criteria for a health-care-associated infection (HCAI). Respiratory samples positive for InfA collected at the same wards within 7 days were chosen for whole-genome sequencing (WGS) and phylogenetic analysis was performed to detect clustering. For reference, concurrent InfA strains from patients with community-acquired infection were included. RESULTS We identified a total of 435 InfA cases, of which 114 (26%) met the HCAI-criteria. The overall 30-day mortality rate was higher among patients with HCAI (9.6% vs. 4.6% among non-HCAI), although the difference was not statistically significant in multivariable analysis, where age was the only independent risk factor for death (p<0.05). We identified 8 closely related clusters (involving ≥3 cases) and another 10 pairs of strains supporting in-ward transmission. CONCLUSION We found that in-ward transmission of InfA occurs frequently and that health-care-associated influenza may have a severe outcome. WGS may be used for outbreak investigations as well as for evaluation of the effect of preventive measures.

[1]  Sunando Roy,et al.  Whole-genome Sequencing Provides Data for Stratifying Infection Prevention and Control Management of Nosocomial Influenza A , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  P. Kelly,et al.  Hospital-acquired influenza in an Australian tertiary Centre 2017: a surveillance based study , 2019, BMC Pulmonary Medicine.

[3]  O. Ergonul,et al.  Predictors of fatality in influenza A virus subtype infections among inpatients in the 2015-2016 season. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  I. Bakken,et al.  Burden of medically attended influenza in Norway 2008‐2017 , 2019, Influenza and other respiratory viruses.

[5]  J. Bloom,et al.  Within-Host Evolution of Human Influenza Virus. , 2018, Trends in microbiology.

[6]  J. Westin,et al.  Molecular characterization of a nosocomial outbreak of influenza B virus in an acute care hospital setting , 2018, Journal of Hospital Infection.

[7]  J. Bresee,et al.  Progress and Remaining Gaps in Estimating the Global Disease Burden of Influenza , 2018, Emerging infectious diseases.

[8]  D. Schriger,et al.  Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. , 2018, The New England journal of medicine.

[9]  D. Pillay,et al.  Use of Whole-Genome Sequencing in the Investigation of a Nosocomial Influenza Virus Outbreak , 2018, The Journal of infectious diseases.

[10]  M. Kretzschmar,et al.  Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  A. Sing,et al.  Whole genome sequencing identifies influenza A H3N2 transmission and offers superior resolution to classical typing methods , 2018, Infection.

[12]  K. Johansen,et al.  How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015 , 2018, Vaccine.

[13]  L. Rosella,et al.  Acute Myocardial Infarction after Laboratory‐Confirmed Influenza Infection , 2018, The New England journal of medicine.

[14]  Miguel Pinheiro,et al.  INSaFLU: an automated open web-based bioinformatics suite “from-reads” for influenza whole-genome-sequencing-based surveillance , 2018, Genome Medicine.

[15]  Jan Kyncl,et al.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.

[16]  P. Vanhems,et al.  Definition of healthcare‐associated influenza: A review and results from an international survey , 2017, Influenza and other respiratory viruses.

[17]  Richard A. White,et al.  Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  N. Ikonen,et al.  Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017 , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[19]  F. Alvarez-lerma,et al.  Characteristics of patients with hospital-acquired influenza A (H1N1)pdm09 virus admitted to the intensive care unit. , 2017, The Journal of hospital infection.

[20]  Pardis C Sabeti,et al.  Genomic Analysis of Viral Outbreaks. , 2016, Annual review of virology.

[21]  P. Vanhems,et al.  Nosocomial influenza: encouraging insights and future challenges , 2016, Current opinion in infectious diseases.

[22]  C. Reed,et al.  Estimating Influenza Disease Burden from Population-Based Surveillance Data in the United States , 2015, PloS one.

[23]  S. Olofsson,et al.  Comparison of the FilmArray assay and in-house real-time PCR for detection of respiratory infection , 2014, Scandinavian journal of infectious diseases.

[24]  C. Macintyre,et al.  Mortality Attributable to Seasonal and Pandemic Influenza, Australia, 2003 to 2009, Using a Novel Time Series Smoothing Approach , 2013, PloS one.

[25]  P. Kelly,et al.  Hospital‐acquired influenza in an Australian sentinel surveillance system , 2013, The Medical journal of Australia.

[26]  Hong Zhou,et al.  Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  R. Jiménez-García,et al.  Pandemic influenza hospitalization in Spain (2009): Incidence, in-hospital mortality, comorbidities and costs , 2012, Human vaccines & immunotherapeutics.

[28]  A. Osterhaus,et al.  Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis. , 2011, Vaccine.

[29]  Benjamin J Cowling,et al.  Viral Shedding and Clinical Illness in Naturally Acquired Influenza Virus Infections , 2010, The Journal of infectious diseases.

[30]  B. Cowling,et al.  Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Derek A T Cummings,et al.  Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. , 2009, The New England journal of medicine.

[32]  Liam Smeeth,et al.  Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. , 2009, The Lancet. Infectious diseases.

[33]  Stefan Gravenstein,et al.  Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[35]  Cécile Viboud,et al.  Trends for Influenza-related Deaths during Pandemic and Epidemic Seasons, Italy, 1969–2001 , 2007, Emerging infectious diseases.

[36]  F. Hayden,et al.  Influenza in the acute hospital setting. , 2002, The Lancet. Infectious diseases.

[37]  L. Grohskopf,et al.  Effect of influenza vaccination of healthcare personnel on morbidity and mortality among patients: systematic review and grading of evidence. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  Nicholas S. Kelley,et al.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[39]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[40]  M. Pallen,et al.  Outbreaks: Defi Nition and Classifi Cation Genomics and Outbreak Investigation: from Sequence to Consequence , 2022 .